Treating Obesity First: Exploring the Role of Amylin Analogues in the Future of Obesity Care

Industry programs may be promotional activities and are not approved for CME/CE credit unless indicated. The editorial style and content of the below information, as well as the opinions expressed by presenters, are those of the sponsor or presenter and are not supported, endorsed, or accredited by The Obesity Society.